These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1763 related articles for article (PubMed ID: 27705931)
1. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3. Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931 [TBL] [Abstract][Full Text] [Related]
2. miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal. Lulli V; Buccarelli M; Martini M; Signore M; Biffoni M; Giannetti S; Morgante L; Marziali G; Ilari R; Pagliuca A; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L Oncotarget; 2015 Nov; 6(35):37241-56. PubMed ID: 26437223 [TBL] [Abstract][Full Text] [Related]
3. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth. Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911 [TBL] [Abstract][Full Text] [Related]
4. miRNA-429 Inhibits Astrocytoma Proliferation and Invasion by Targeting BMI1. Peng G; Liao Y; Shen C Pathol Oncol Res; 2017 Apr; 23(2):369-376. PubMed ID: 27663885 [TBL] [Abstract][Full Text] [Related]
5. Targeting of BMI-1 with PTC-209 inhibits glioblastoma development. Kong Y; Ai C; Dong F; Xia X; Zhao X; Yang C; Kang C; Zhou Y; Zhao Q; Sun X; Wu X Cell Cycle; 2018; 17(10):1199-1211. PubMed ID: 29886801 [TBL] [Abstract][Full Text] [Related]
6. Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors. Wang Z; Yang J; Xu G; Wang W; Liu C; Yang H; Yu Z; Lei Q; Xiao L; Xiong J; Zeng L; Xiang J; Ma J; Li G; Wu M Oncotarget; 2015 Feb; 6(5):3147-64. PubMed ID: 25605243 [TBL] [Abstract][Full Text] [Related]
7. MiR-152 functions as a tumor suppressor in glioblastoma stem cells by targeting Krüppel-like factor 4. Ma J; Yao Y; Wang P; Liu Y; Zhao L; Li Z; Li Z; Xue Y Cancer Lett; 2014 Dec; 355(1):85-95. PubMed ID: 25218589 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1. Bier A; Giladi N; Kronfeld N; Lee HK; Cazacu S; Finniss S; Xiang C; Poisson L; deCarvalho AC; Slavin S; Jacoby E; Yalon M; Toren A; Mikkelsen T; Brodie C Oncotarget; 2013 May; 4(5):665-76. PubMed ID: 23714687 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma. Tian T; Mingyi M; Qiu X; Qiu Y Oncotarget; 2016 Nov; 7(48):79584-79595. PubMed ID: 27792996 [TBL] [Abstract][Full Text] [Related]
10. Bmi1 regulates human glioblastoma stem cells through activation of differential gene networks in CD133+ brain tumor initiating cells. Vora P; Seyfrid M; Venugopal C; Qazi MA; Salim S; Isserlin R; Subapanditha M; O'Farrell E; Mahendram S; Singh M; Bakhshinyan D; Chokshi C; McFarlane N; Dvorkin-Gheva A; Brown KR; Murty N; Moffat J; Bader GD; Singh SK J Neurooncol; 2019 Jul; 143(3):417-428. PubMed ID: 31115870 [TBL] [Abstract][Full Text] [Related]
11. Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152. Yao Y; Ma J; Xue Y; Wang P; Li Z; Liu J; Chen L; Xi Z; Teng H; Wang Z; Li Z; Liu Y Cancer Lett; 2015 Apr; 359(1):75-86. PubMed ID: 25578780 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9. Liu N; Zhang L; Wang Z; Cheng Y; Zhang P; Wang X; Wen W; Yang H; Liu H; Jin W; Zhang Y; Tu Y Oncotarget; 2017 Mar; 8(12):19244-19254. PubMed ID: 27911279 [TBL] [Abstract][Full Text] [Related]
13. Tumor suppressor miR-181c attenuates proliferation, invasion, and self-renewal abilities in glioblastoma. Ruan J; Lou S; Dai Q; Mao D; Ji J; Sun X Neuroreport; 2015 Jan; 26(2):66-73. PubMed ID: 25494473 [TBL] [Abstract][Full Text] [Related]
14. Differential expression of miR16 in glioblastoma and glioblastoma stem cells: their correlation with proliferation, differentiation, metastasis and prognosis. Tian R; Wang J; Yan H; Wu J; Xu Q; Zhan X; Gui Z; Ding M; He J Oncogene; 2017 Oct; 36(42):5861-5873. PubMed ID: 28628119 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-29a inhibits glioblastoma stem cells and tumor growth by regulating the PDGF pathway. Yang Y; Dodbele S; Park T; Glass R; Bhat K; Sulman EP; Zhang Y; Abounader R J Neurooncol; 2019 Oct; 145(1):23-34. PubMed ID: 31482267 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1. Tu Y; Gao X; Li G; Fu H; Cui D; Liu H; Jin W; Zhang Y Cancer Res; 2013 Oct; 73(19):6046-55. PubMed ID: 23950210 [TBL] [Abstract][Full Text] [Related]
17. The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness. Gao X; Jin W Cancer Lett; 2014 Oct; 353(1):25-31. PubMed ID: 25042866 [TBL] [Abstract][Full Text] [Related]
18. A Sox2:miR-486-5p Axis Regulates Survival of GBM Cells by Inhibiting Tumor Suppressor Networks. Lopez-Bertoni H; Kotchetkov IS; Mihelson N; Lal B; Rui Y; Ames H; Lugo-Fagundo M; Guerrero-Cazares H; Quiñones-Hinojosa A; Green JJ; Laterra J Cancer Res; 2020 Apr; 80(8):1644-1655. PubMed ID: 32094299 [TBL] [Abstract][Full Text] [Related]
19. NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200. Fu J; Rodova M; Nanta R; Meeker D; Van Veldhuizen PJ; Srivastava RK; Shankar S Neuro Oncol; 2013 Jun; 15(6):691-706. PubMed ID: 23482671 [TBL] [Abstract][Full Text] [Related]
20. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells. Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]